Clinical trial condition

NHL

Explore clinical trials studying NHL. Study availability and eligibility vary by location and protocol.

24 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

NHL trial results

Recruiting

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

NCT04002947

Conditions: DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT07283796

Conditions: NHL
Locations: Chinese Academy of Medical Sciences Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

NCT06119685

Conditions: Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations: Valkyrie Clinical Trials Los Angeles, California, United States

Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States

Emory University Hospital Atlanta, Georgia, United States

University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS

NCT06731699

Conditions: AML, NHL
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL

NCT05641428

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: NL-Amsterdam-AMC Amsterdam, Netherlands

NL-Groningen-UMCG Groningen, Netherlands

NL-Leiden-LUMC Leiden, Netherlands

NL-Maastricht-MUMC Maastricht, Netherlands

View Trial Details

Recruiting

Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients

NCT04440436

Conditions: NHL
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

NCT06385522

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma

NCT06486337

Conditions: NHL
Locations: Not specified

View Trial Details

Completed

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

NCT02315612

Conditions: ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

NCT05371054

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

NHL

NHL trial results

Related conditions